Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Amicus Therapeutics Inc
FOLD | US
14.49
USD0.03
0.21%
FOLD | US
Loading StockChartView...
About Amicus Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
14.49
Open
14.49
High
14.50
Low
14.49
Amicus Therapeutics Inc. a biotechnology company focuses on discovering developing and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia Pennsylvania.
View LessFOLD | US
Risk
1.5
Sharpe
2.17
Luna's Score
64/100
Recommendation
Hold
Luna says (FOLD | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Midcap (2B - 10B USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
1.2%1 month
1.5%3 months
1.7%6 months
45.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
53.19
Price to book
26.63
Debt to equity
3.35
Debt to assets
0.59
Ent. to EBITDA
-35.99
Ent. to rev.
8.15
PEG
-0.18
Other Fundamentals
EBITDA
-16.68M
MarketCap
4.30B
MarketCap(USD)
4.30B
Div. yield
-
Op. margin
11.82
Erngs. growth
-
Rev. growth
34.00
Ret. on equity
-97.94
Short ratio
9.99
Short perc.
7.37
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.05
Range1M
0.10
Range3M
0.24
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.51
Price X volume
54.63M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -35.99 | 0.53 | Cheaper |
| Ent. to Revenue | 8.15 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 26.63 | 15.55 | Expensive |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 1.72 | 72.80 | Lower Risk |
| Debt to Equity | 3.35 | -1.23 | Expensive |
| Debt to Assets | 0.59 | 0.25 | Expensive |
| Market Cap | 4.30B | 3.66B | Par |
